Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mariam Obeid"'
Autor:
Nicolò Matteo Luca Battisti, Laura Morrison, Tamsin Nash, Nishanti Senthivel, Samantha Kestenbaum, Parvin Begum, Mariam Obeid, William Hayhurst, Dorothy Yang, Shafiah Gafoor, Caroline Brown, Farah Rehman, Laura Kenny, Olivia Hatcher, Susan Susan, Jennet Williams, Anna Brown, Hamoun Rozati, Alexandros Alexandros, Elinor Sawyer, Charalampos Gousis, Eleni Karapanagiotou, Anna Rigg, Kleopatra Rapti, Rebecca Roylance, Mark Beresford, Abigail L Gee, Apostolos Konstantis, Judy King, Mark Nathan, Emma Spurrell, Mark Pearce, Dane Bradwell, Arshi Denton, Kate Swain, Sophie McGrath, Mark Allen, Alistair Ring, Stephen Johnston, Fharat Raja
Publikováno v:
Cancer Research. 82:P1-17
Background Abemaciclib is approved in 1st and 2nd line for hormone receptor (HR)-positive HER2-negative advanced breast cancer (ABC). However, outcomes on this agent are unclear in the real world.We determined the safety and efficacy profile of abema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46078e8a48bea41baf70095f039369ae
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-08
https://doi.org/10.1158/1538-7445.sabcs21-p1-17-08
Autor:
Jaishree Bhosle, Michael Davidson, Mary O'Brien, Anna Minchom, Mariam Obeid, Abdul Muhith, Sanjay Popat, Kroopa Joshi, Nadia Yousaf, C. Milner-Watts
Publikováno v:
Lung Cancer (Amsterdam, Netherlands)
Durvalumab is the first approved adjuvant immunotherapy agent for patients with stage III NSCLC treated with concurrent chemoradiotherapy and is associated with improved overall survival. In order to minimise the number of hospital visits for patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2504854bc6ae53fc22d32b9cc475d893
https://doi.org/10.1016/j.lungcan.2021.04.021
https://doi.org/10.1016/j.lungcan.2021.04.021
Autor:
Nicolò Matteo Luca Battisti, Maria Sol Andres, Karla A Lee, Tharshini Ramalingam, Tamsin Nash, Stephanie Mappouridou, Nishanthi Senthivel, Kalaprapa Asavisanu, Mariam Obeid, Elli-Sophia Tripodaki, Vasileios Angelis, Emily Fleming, Emily F Goode, Susan John, Stuart D Rosen, Mark Allen, Susannah Stanway, Alexander R Lyon, Alistair Ring
PurposeTrastuzumab improves survival in patients with HER2+ early breast cancer. However, cardiotoxicity remains a concern, particularly in the curative setting, and there are limited data on its incidence outside of clinical trials. We retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc979bf5e03cc7af13cb3853bbee0744
https://doi.org/10.21203/rs.3.rs-251663/v1
https://doi.org/10.21203/rs.3.rs-251663/v1
Autor:
Kalaprapa Asavisanu, Susannah Stanway, Tamsin Nash, Emily Fleming, Susan John, Stephanie Mappouridou, Nishanthi Senthivel, Stuart D. Rosen, Nicolò Matteo Luca Battisti, Elli-Sophia Tripodaki, Sivatharshini Ramalingam, M. Allen, Alexander R. Lyon, Karla A. Lee, Maria Sol Andres, Alistair Ring, Emily Goode, Vasileios Angelis, Mariam Obeid
Publikováno v:
Breast cancer research and treatment. 188(1)
Trastuzumab improves survival in patients with HER2+ early breast cancer. However, cardiotoxicity remains a concern, particularly in the curative setting, and there are limited data on its incidence outside of clinical trials. We retrospectively eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f110ad5a004bab50c6c12cc24da9cd
https://pubmed.ncbi.nlm.nih.gov/33818652
https://pubmed.ncbi.nlm.nih.gov/33818652
Publikováno v:
Lecture Notes in Computer Science ISBN: 9783030229986
IEA/AIE
IEA/AIE
Medical diagnosis can be defined as the detection of a disease by examining a patient’s signs, symptoms and history. Diagnostic reasoning can be viewed as a process of testing hypotheses guided by symptoms and signs. Solutions to diagnostic problem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f3d5b06bdf5b0449d613b7240041278
https://doi.org/10.1007/978-3-030-22999-3_33
https://doi.org/10.1007/978-3-030-22999-3_33
Autor:
C. Milner-Watts, Kroopa Joshi, Mariam Obeid, Shelize Khakoo, Anna Minchom, Jaishree Bhosle, A. Muhith, Mary O'Brien
Publikováno v:
Annals of Oncology
Background: Durvalumab, an anti-PD-L1 agent, is approved for use as an adjuvant treatment of patients with stage III NSCLC previously treated with concurrent chemoradiotherapy scheduled as two-weekly infusions for one year The COVID-19 pandemic has n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a2f0b1ecd82cfdf3fb62d9bd18cc14
http://europepmc.org/articles/PMC7506560
http://europepmc.org/articles/PMC7506560
Autor:
Vasileios Angelis, E-S. Tripodaki, S. Mappouridou, Karla A. Lee, Alistair Ring, M.S. Andres, T. Nash, Emily Goode, N. Senthivel, K. Asavisanu, S. John, Alexander R. Lyon, N.M.L. Battisti, E. Fleming, Mariam Obeid, M. Allen
Publikováno v:
Annals of Oncology. 31:S330
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d38263b4a1154e41829780da9e9628fb
https://doi.org/10.1016/j.annonc.2020.08.344
https://doi.org/10.1016/j.annonc.2020.08.344
Autor:
Tharwa Bilbeisi, Razaq Almasry, Mariam Obeidat, Mona Mohammad, Imad Jaradat, Hadeel Halalsheh, Ayat Alni’mat, Danah Kanj Ahmad, Nour Alsaket, Mustafa Mehyar, Ibrahim Al-Nawaiseh, Yacoub A. Yousef
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
PurposeTo analyze causes and prognostic factors for death among Retinoblastoma (Rb) patients treated at a single specialized tertiary cancer center in Jordan.MethodsWe reviewed the mortality causes for all Rb patients who have been treated at the Kin
Externí odkaz:
https://doaj.org/article/efc5c030a5284fdf9e4a774f243b947a